About: Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 July 2009

AttributesValues
rdf:type
description
  • videnskabelig artikel (da)
  • article científic (ca)
  • articolo scientifico (it)
  • artigo científico (pt)
  • bilimsel makale (tr)
  • vedecký článok (sk)
  • vetenskaplig artikel (sv)
  • vědecký článek (cs)
  • wetenschappelijk artikel (nl)
  • wissenschaftlicher Artikel (de)
  • научни чланак (sr)
  • article scientifique (fr)
  • artículu científicu espublizáu en 2009 (ast)
  • наукова стаття, опублікована в липні 2009 (uk)
  • scientific article published on 05 July 2009 (en)
  • مقالة علمية نشرت في 05 يوليو 2009 (ar)
publication date
publication date
cites work
cites work
author name string
author name string
  • P B Mortensen
  • P B Jeppesen
  • B Quistorff
  • H B Nielsen
  • I B Gottschalck
  • S S Poulsen
rdfs:label
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (en)
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (nl)
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (ast)
skos:prefLabel
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (en)
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (nl)
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (ast)
name
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (en)
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (nl)
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (ast)
author
author
title
title
  • Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life (en)
page(s)
page(s)
  • 425759
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 19590736
published in
published in
volume
volume
  • 2009
DOI
DOI
DOI
  • 10.1155/2009/425759
copyright license
copyright status
copyright license
copyright status
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software